跳至主要内容
临床试验/NCT00487526
NCT00487526Unknown1 期

Clinical Evaluation of the Effect of Duodenal Jejunal Bypass on Type Two Diabetes in Non Obese Adults

Ferzli, George S., M.D. F.A.C.S.1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2007年6月1日最近更新:
适应症

试验速览

阶段
1 期
发起方
入组人数
50
试验地点
1
主要终点
control of type 2 diabetes in non obese adults

研究概览

简要总结

Study the effect of Duodenal jejunal bypass on human adults with type 2 diabetes.

详细描述

Adults non obese ( BMI less than 34 ) will undergo duodenal jejunal bypass. The Outcome measures: Blood Sugar, Insulin,HbA1c, CCK,Gastrin, GIP1and 2, Ghrelin, Cholesterol, Triglycerides,FFA, C-Peptide.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults age 20-65
  • Clinical diagnosis of type 2 diabetes
  • Non obese with BMI less than
  • Oral agents or insulin to control T2DM.
  • Inadequate control of diabetes as defined as HbA1c>/7.5
  • Understanding of the mechanisms of action of the treatment

排除标准

  • Children with type 1 diabetes
  • Obese with BMI over 34
  • Coagulopathy
  • Liver cirrhosis
  • Unable to comply with study requirements, follow-up or give valid consent
  • Currently pregnant
  • Previous upper abdominal surgery
  • Inabilty to tolerate general anesthesia

结局指标

主要结局

control of type 2 diabetes in non obese adults

时间窗: two years

次要结局

  • CCK FFA,Cholesterol,Ghrelin,C-peptide,HbA1c,Gastrin,GIP,Triglycerides,Insulin(2 years)

研究者

发起方
Ferzli, George S., M.D. F.A.C.S.
申办方类型
Indiv

研究点 (1)

Loading locations...

相似试验